🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of the study is to identify a dose and schedule of CC-486 that can...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2015-04-29
Trial ID
NCT02343536
Treatments Being Tested
This study focuses on finding a safe and tolerable dose for a three-drug re...
Status
Terminated
Location
University of Chicago Medical Center
Start Date
2021-09-01
Trial ID
NCT04722601
Treatments Being Tested
This phase II/III trial compares the side effects and activity of oral azac...
Status
Active Not Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2021-05-20
Trial ID
NCT04799275
You are being asked to take part in this study because you have advanced me...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-02-14
Trial ID
NCT02816021
Treatments Being Tested
Background: T-cell lymphomas (TCLs) are rare cancers. Many types of TCLs d...
Status
Withdrawn
Location
National Institutes of Health Clinical Center
Start Date
2022-11-03
Trial ID
NCT04639843
Treatments Being Tested
Background: Mature T-cell malignancies (TCMs) are a rare group of cancers ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2020-12-17
Trial ID
NCT04447027
Response Rate...
Status
Completed
Location
University of Southern California
Start Date
2013-11-06
Trial ID
NCT01928576
Treatments Being Tested
The goal of this clinical study is to learn more about the safety and dosin...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2021-06-28
Trial ID
NCT04778410
Treatments Being Tested
This phase II trial studies the effect of duvelisib or CC-486 and usual che...
Status
Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2021-10-08
Trial ID
NCT04803201
Treatments Being Tested
This is a phase II, multi-center study to determine the efficacy and safety...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2018-06-01
Trial ID
NCT03542266
Treatments Being Tested